Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 22, 2018
Patent Application Number
15065707
Date Filed
March 9, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
Antibody drug conjugates (ADC's) that bind to FLT3 protein and variants thereof are described herein. FLT3 exhibits a distinct and limited expression pattern in normal adult tissue(s), and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
